Access to Medicine in Post-LDC Era: Challenges in Intellectual Property Law Framework of Bangladesh (original) (raw)
Bangladesh Journal of Bioethics 2010; 1(3):43-46 INTELLECTUAL PROPERTY RIGHTS AND DEVELOPING COUNTRIES
Arif Hossain
2016
View PDFchevron_right
Pharmaceutical Patent Protection and Trips Challenges for Bangladesh: An Appraisal of Bangladesh's Patent Office and Department of Drug Administration
Monirul Azam
2011
View PDFchevron_right
Legal & Intellectual Property Dimension of Health & Access to Medicines in India
Dr.Mohammad Rauf, Md. Zafar M A H F O O Z Nomani
Indian Journal of Forensic Medicine & Toxicology, 2020
View PDFchevron_right
THE HUMAN RIGHT TO HEALTH, ACCESS TO DRUGS AND GLOBAL MEDICAL PATENTS-INDIAN JOURNAL OF INTERNATIONAL LAW, Vol 49, no. 3(JULY-SEPTEMBER) 2009.doc
B.C. Nirmal
View PDFchevron_right
TRIPS and Innovative Capacity of Bangladesh's Pharmaceutical Industry: Promotion of Access to Essential Medicine
Mohammad Aktarul Alam Chowdhury
View PDFchevron_right
An A-Z of Pharma Industry Review: Bangladesh Perspective
Abdul Kader Mohiuddin
View PDFchevron_right
Intellectual Properties: Bangladesh Has A Long Way to Go
Samiun Hasib Bhuiyan
View PDFchevron_right
Application of Intellectual Property Law: Bangladesh Perspective
Arafat Arafat
View PDFchevron_right
Intellectual Properties: Bangladesh Approach
Milan Hossain
View PDFchevron_right
Introduction: Access to essential medicines: public health and international law
Thomas Pogge
Cambridge University Press eBooks, 2010
View PDFchevron_right
A Review on Revolution of Pharmaceutical Sector in Bangladesh after Liberation War and Future Prospects and Challenges
Rahman ripon
International Journal of Pharmaceutical Investigation
View PDFchevron_right
Bangladesh’s Patent Act – Aligning with Global Standards or Falling Short? A Comparative Study
Fardeen Bin Abdullah
World Journal of Sociology and Law, 2024
View PDFchevron_right
Intellectual property and innovation in least developed countries: Pharmaceuticals, agro-processing and textiles and RMG in Bangladesh
padmashree gehl sampath
merit.unu.edu
View PDFchevron_right
TRIPS and the pharmaceutical industry in Bangladesh: Towards a national strategy
Quazi Sakib
2003
View PDFchevron_right
Intellectual Property and Access to Essential Pharmaceuticals Re
Chikosa Banda
View PDFchevron_right
Access to Medicines and Intellectual Property Rights
Abdulkadir Civan
2000
View PDFchevron_right
Intellectual Property and Global Health: From Corporate Social Responsibility to the Access to Knowledge Movement (2013)
Cristian Timmermann, Henk van den Belt
Liverpool Law Review, 2013
View PDFchevron_right
Intellectual property rights and public health: an impediment to access to medicines and health technology innovation?
nerina boschiero
Stato, Chiese e Pluralismo Confessionale, 2017
View PDFchevron_right
Joo-Young Lee: A human rights framework for intellectual property, innovation and access to medicines : Ashgate, 2015, 300 pp, $49.95 (paperback), ISBN: 978-1-4724-1061-0
Daniele Ruggiu
Theoretical medicine and bioethics, 2018
View PDFchevron_right
TRIPS Agreement and Public Health: Implications and Challenges for Bangladesh
Mohammad Towhidul Islam
International Trade Law and Regulation, 2011
View PDFchevron_right
Ethical Relation between Physicians and Pharmaceutical Industries in the Perspectives of Bangladesh
Shahinul Alam
Bangladesh Journal of Bioethics, 2015
View PDFchevron_right
Intellectual Property Rights: Need for a Sui Generis Regime for Non-codified Traditional Medicine in India
Am Jour of Phytomed & Clinical Therapeut
American Journal of Phytomedicine and Clinical Therapeutics, 2014
View PDFchevron_right
Resistance and Consistent: Access to Medicines and Patent Law Reforms in India and China
Yuan qiong Hu
SOAS School of Law Working Paper Series, 2016
View PDFchevron_right
Chicago-Kent Journal of Intellectual Property Globalizing Standard of Patent Protection in WTO Law and Policy Options for the LDCs: The Context of Bangladesh
Monirul Azam
View PDFchevron_right
An A-Z Pharmaceutical Industry: Bangladesh Perspective
Abdul Kader Mohiuddin
Industry Review, 2019
View PDFchevron_right
Interface Between Human Rights and Intellectual Property Rights with Special Reference to Patent Regime and Right to Health in India
jagdish khobragade
Journal of Intellectual Property Rights
View PDFchevron_right
National drug policy reform for noncommunicable diseases in low-resource countries: an example from Bangladesh
Anwar Islam
Bulletin of the World Health Organization, 2016
View PDFchevron_right
Access to Essential Medicine: Making a Case for Compulsory Licensing of Pharmaceutics in Pakistan
tooba akhtar
Journal of Law & Social Studies, 2019
View PDFchevron_right
Editorial Bangladesh Pharmaceutical Industry: Perspective and the Prospects
Ash Maitra
View PDFchevron_right
Patents and access to drugs in developing countries: an ethical analysis
Sigrid Sterckx
Developing World Bioethics, 2004
View PDFchevron_right
Intellectual property rights and health: The constraints of WHO authority and the rise of global health governance as an element of contestation
Wolfgang Hein
2016
View PDFchevron_right
Implementation and Impact of Intellectual Property Rights in Perspective of Bangladesh
Mohammed Rahel
International Journal of Business and Technopreneurship, 2017
View PDFchevron_right
Intellectual Property and the Global Crisis of Non-Communicable Disease
Faisal Chaudhry
North Carolina Journal of Law & Technology, 2017
View PDFchevron_right
INTERACTION BETWEEN PATENT PROTECTION AND ACCESS TO ESSENTIAL MEDICINES - THE POTENTIAL CONFLICT BETWEEN RIGHTS TO HEALTH AND PROPERTY RIGHTS
Martha Chikowore, Biruk Haile, Gustavo Schötz
View PDFchevron_right
The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS Agreement
André LOUA
2020
View PDFchevron_right